HANTECH BIO-TECH (Stock Code: 1294) is scheduled to officially list on the Taipei Exchange (TPEx) on Sep. 26 at NTD 118 per share.
The company primarily provides comprehensive one-stop contract manufacturing services for health supplements, covering everything from formulation design to retort pouch filling and packaging.
Founded in 2007, HANTECH BIO-TECH initially focused on the sale of traditional Chinese medicinal ingredients, including Guilu-related materials. In 2010, the company began developing low-temperature grinding technology for ultra-fine nano pearl powder. In 2012, it introduced retort pouch filling machines and sterilization equipment and expanded into health supplement filling and contract manufacturing services.
Chairman Lee Yu-Lin noted that the company faced significant challenges in its early years, operating at a loss for 10 consecutive years. What was the turning point that finally enabled HANTECH to turn its business around in its 11th year?
Source: